株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

組織工学(ティッシュエンジニアリング)の世界市場:市場規模、シェア、動向、予測 ~2026年

Tissue Engineering Market - Size, Share, Trends, and Forecast to 2026

発行 Coherent Market Insights 商品コード 738725
出版日 ページ情報 英文 175 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=110.43円で換算しております。
Back to Top
組織工学(ティッシュエンジニアリング)の世界市場:市場規模、シェア、動向、予測 ~2026年 Tissue Engineering Market - Size, Share, Trends, and Forecast to 2026
出版日: 2018年10月10日 ページ情報: 英文 175 Pages
概要

組織工学(ティッシュエンジニアリング)は、生物学、生物物理学、または生体力学を適用し、生物学的代用品の開発に主に焦点を当てた学際的な分野です。移植手術におけるドナー不足に対応する手段として注目を集めているほか、再生医療では重要な役割を果たしています。

当レポートでは、世界の組織工学(ティッシュエンジニアリング)市場を調査し、市場の概要、材料・用途・地域別の市場規模の推移と予測、市場の成長要因および阻害要因の分析、市場機会、競合情勢、主要企業のプロファイルなど、包括的な情報を提供しています。

目次

第1章 調査目的と前提条件

  • 調査目的
  • 前提条件
  • 略語

第2章 市場概要

  • レポート概要
    • 市場の定義と範囲
  • エグゼクティブサマリー
    • 市場スニペット:材料別
    • 市場スニペット:用途別
    • 市場スニペット:地域別
  • コヒーレントオポチュニティーマップ(COM)

第3章 市場力学、規制、動向分析

  • 市場力学
    • 成長要因
    • 阻害要因
    • 市場機会
  • 影響分析
  • 市場動向
  • 主な開発動向
  • 技術進歩
  • 償還シナリオ
  • 疫学分析
  • PEST分析

第4章 世界の組織工学(ティッシュエンジニアリング)市場:材料別

  • イントロダクション
  • 合成
  • 生物学的
  • その他

第5章 世界の組織工学(ティッシュエンジニアリング)市場:用途別

  • イントロダクション
  • 皮膚科
  • 整形外科
  • 歯科
  • 神経科
  • その他

第6章 世界の組織工学(ティッシュエンジニアリング)市場:地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • アフリカ
  • 中東

第7章 競合情勢

  • ヒートマップ解析
  • 企業プロファイル
    • Acelity L.P. Inc.
    • Allergan Plc
    • Athersys, Inc.
    • B. Braun
    • BioMimetic Therapeutics
    • Bio Tissue Technologies
    • C. R. Bard
    • International Stem Cell
    • Integra Lifesciences
    • Medtronic, Inc.
    • Organogenesis Inc.
    • Osiris Therapeutics
    • RTI surgical, Inc.
    • Stryker Corporation
    • Tissue Regenix Group Plc
    • Zimmer Biomet
  • アナリストの見解

第8章 セクション

  • 参考文献
  • 調査方法
  • Coherent Market Insightsについて
目次

Tissue engineering is a scientific field majorly focused on the development of tissue and organ substitutes by controlling biophysical, biological, and/or biomechanical parameters in the laboratory. Tissue engineering has emerged as a rapidly expanding approach to address shortage of organs in transplantation procedures and is a major component of regenerative medicine. The general principles of tissue engineering involve combining living cells with a synthetic or natural support or scaffold to build a three dimensional living construct that is structurally, functionally, and mechanically equal to or better than the tissue that is to be replaced.

Market Dynamics

Scientific advancements in the fields of cell and molecular biology, genetics, biochemistry, biomedical engineering and materials science have opened new growth opportunities in the field of tissue engineering. Rising need for effective regenerative treatments due to the rapidly aging population coupled with increasing population suffering from diseases such as cancer, diabetes, and obesity and growth in burn and trauma cases are expected to drive the tissue engineering market growth during the forecast period. According to the World Health Organization (WHO), global diabetic population is expected to reach 336 million by 2030, from 270 million in 2015.

However, tissue engineering processes used for development of complex tissues or organs, such as heart, is facing challenges such as dearth of cell sources, biomaterials, vascularization of engineered tissues, and design of drug delivery systems. Moreover, harvesting autografts is painful, expensive, constrained by anatomical limitations and donor-site morbidity due to hematoma and infection, which is hindering growth of the market.

Key features of the study:

This report provides in-depth analysis of the tissue engineering market, market size (US$ Mn), and Compound Annual Growth Rate (CAGR (%)) for the forecast period: 2018 - 2026, considering 2017 as the base year

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players

It profiles key players in the global tissue engineering market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies

Key players covered as a part of this study include Acelity L.P. Inc., Allergan Plc., Athersys, Inc., B. Braun, BioMimetic Therapeutics, Bio Tissue Technologies, C. R. Bard, International Stem Cell, Integra Lifesciences, Medtronic, Inc., Organogenesis Inc., Osiris Therapeutics, RTI surgical, Inc., Stryker Corporation, Tissue Regenix Group Plc., and Zimmer Biomet

Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics

The global tissue engineering market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

  • Global Tissue Engineering Market, By Material Type:
  • Synthetic
  • Biological
  • Others
  • Global Tissue Engineering Market, By Application:
  • Dermal
  • Orthopedic
  • Dental
  • Neurology
  • Others
  • Global Tissue Engineering Market, By Region:
  • North America
  • By Country:
  • U.S.
  • Canada
  • By Material Type:
  • Synthetic
  • Biological
  • Others
  • By Application:
  • Dermal
  • Orthopedic
  • Dental
  • Neurology
  • Others
  • Europe
  • By Country:
  • U.K.
  • Germany
  • Italy
  • Spain
  • France
  • Russia
  • Rest of Europe
  • By Material Type:
  • Synthetic
  • Biological
  • Others
  • By Application:
  • Dermal
  • Orthopedic
  • Dental
  • Neurology
  • Others
  • Asia Pacific
  • By Country:
  • Australia
  • India
  • China
  • Japan
  • ASEAN
  • South Korea
  • Rest of Asia Pacific
  • By Material Type:
  • Synthetic
  • Biological
  • Others
  • By Application:
  • Dermal
  • Orthopedic
  • Dental
  • Neurology
  • Others
  • Latin America
  • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • By Material Type:
  • Synthetic
  • Biological
  • Others
  • By Application:
  • Dermal
  • Orthopedic
  • Dental
  • Neurology
  • Others
  • Middle East
  • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • By Material Type:
  • Synthetic
  • Biological
  • Others
  • By Application:
  • Dermal
  • Orthopedic
  • Dental
  • Neurology
  • Others
  • Africa
  • By Country:
  • South Africa
  • Central Africa
  • North Africa
  • By Material Type:
  • Synthetic
  • Biological
  • Others
  • By Application:
  • Dermal
  • Orthopedic
  • Dental
  • Neurology
  • Others
  • Company Profiles
  • Acelity L.P. Inc.*
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Allergan Plc.
  • Athersys, Inc.
  • Braun
  • BioMimetic Therapeutics
  • Bio Tissue Technologies
  • R. Bard
  • International Stem Cell
  • Integra Lifesciences
  • Medtronic, Inc.
  • Organogenesis Inc.
  • Osiris Therapeutics
  • RTI surgical, Inc.
  • Stryker Corporation
  • Tissue Regenix Group Plc.
  • Zimmer Biomet

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Material Type
    • Market Snippet, By Application
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Technological Advancements
  • Reimbursement Scenario
  • Epidemiology Analysis
  • PEST Analysis

4. Global Tissue Engineering Market, By Material Type, 2016 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Synthetic
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Biological
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)

5. Global Tissue Engineering Market, By Application, 2016 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Dermal
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Orthopedic
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Dental
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Neurology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)

6. Global Tissue Engineering Market, By Region, 2016 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, By Region, 2016 - 2026
    • Regional Trends
  • North America
    • Market Size and Forecast, By Material Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Application, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • U.S.
    • Canada
  • Europe
    • Market Size and Forecast, By Material Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Application, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Material Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Application, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Market Size and Forecast, By Material Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Application, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Africa
    • Market Size and Forecast, By Material Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Application, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • Northern Africa
    • Central Africa
    • South Africa
  • Middle East
    • Market Size and Forecast, By Material Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Application, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • GCC Countries
    • Israel
    • Rest of Middle East

7. Competitive Landscape

  • Heat Map Analysis
  • Company Profiles
    • Acelity L.P. Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Allergan Plc
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Athersys, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • B. Braun
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • BioMimetic Therapeutics
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Bio Tissue Technologies
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • C. R. Bard
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • International Stem Cell
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Integra Lifesciences
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Medtronic, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Organogenesis Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Osiris Therapeutics
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • RTI surgical, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Stryker Corporation
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Tissue Regenix Group Plc
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Zimmer Biomet
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
  • Analyst Views

8. Section

  • References
  • Research Methodology
  • About Us and Sales Contact
Back to Top